Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Open-label, follow-on Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Distal Diabetic Neuropathy Including a Double-blind, Randomized Time Point Withdrawal Subtrial.

NCT00546351 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.

NCT NCT00546351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00546351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Open-label, follow-on Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Distal Diabetic Neuropathy Including a Double-blind, Randomized Time Point Withdrawal Subtrial.
Lead sponsor
UCB Pharma
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2004
Completion date
January 31, 2011
Enrollment
621 (actual)
Sites
101

Conditions

As the registry lists them; a condition with its own page is linked.

painful diabetic neuropathy